Trials / Active Not Recruiting
Active Not RecruitingNCT06645132
Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.
Pilot Study to Understand the Feasibility of Implementing a Wearable Device Cueing System Following Bone Marrow Transplant
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Medical College of Wisconsin · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-transplant inpatient hospital stay to promote physical recovery and well-being.
Detailed description
Enrolled patients who have been diagnosed with a hematologic malignancy and are scheduled to undergo an allogeneic bone marrow transplant will use a custom-designed wearable device and smartphone application as a behavioral intervention to cue exercise. Participants will be asked to wear the wearable device for the duration of their post-transplant inpatient hospital stay. Aim 1. To examine the potential efficacy of the wearable device + smartphone application to prompt alloBMT patients to move. Aim 2. To receive participant feedback on their experience participating in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | exercise intervention | Exercise intervention leveraging wearable devices and a custom smartphone application to cue exercise as a reminder during idle time during an inpatient hospital stay, post allogenic bone marrow transplant. |
Timeline
- Start date
- 2024-10-28
- Primary completion
- 2025-01-21
- Completion
- 2025-09-01
- First posted
- 2024-10-16
- Last updated
- 2025-02-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06645132. Inclusion in this directory is not an endorsement.